|11.31||+0.10 / +0.89%|
Data as of 3:59pm ET
|11.25||-0.06 / -0.53%|
The 5 analysts offering 12-month price forecasts for Avanir Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 12.20. The median estimate represents a +41.47% increase from the last price of 11.31.
The current consensus among 5 polled investment analysts is to Buy stock in Avanir Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.